Last updated: 2026-09-28 09:00:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $271.87, with a market capitalisation of $653.61B and a P/E ratio of 31.07. Over the past 52 weeks, its price has ranged from $179.80 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$653.61B | |
$270.97 | |
$281.07 | |
$46.25 | |
$271.22 | |
1.14K | |
7.05M | |
31.07 | |
$281.07 | |
$179.80 | |
1.93% | |
-- |
Johnson & Johnson (JNJ) is trading at $271.87 in pre-market trading as of 2026-09-28 08:58:00, up 0.24% ($0.65) from the previous close of $271.22
Pre-market trading shows how investors are pricing JNJ before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $270.22 to $271.87, representing a gain of 0.61% ($1.65).
The stock traded between $265.04 and $275.23 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 7.17 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 90.9%
JNJ is currently trading at $271.87, placing it 90.9% of the way from its 52-week low of $179.80 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.